- Filed
- Feb 19, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 19, 2025 | 4.2M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $15.25M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2023 | $3.15M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $14.7M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $16M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $7.19M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $5.34M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $7.19M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $5.47M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $18.89M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $18.25M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $19.12M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $18.73M |
| Sga Expense | Q2 2025 · Dec 31, 2024 | $62.77K |
| Sga Expense | Q2 2025 · Dec 31, 2024 | $125.75K |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $56.08K |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $111.93K |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 17.52M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 17.56M sh |
| Capex | Q2 2025 · Dec 31, 2023 | $589 |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$5.89M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.06 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.19 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.06 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.19 |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$1.22M |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$3.56M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | −$15.64K |
| Gross Profit | Q2 2025 · Dec 31, 2023 | −$122.66K |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $976.88K |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $1.98M |
| Revenue | Q2 2025 · Dec 31, 2023 | $961.24K |
| Revenue | Q2 2025 · Dec 31, 2023 | $1.86M |